Quarterly report pursuant to Section 13 or 15(d)

Revenue Disaggregation

v3.22.2
Revenue Disaggregation
 3 Months Ended
Jun. 30, 2022
Revenue from Contract with Customer [Abstract]  
Revenue Disaggregation

 

Note 10. Revenue Disaggregation

 

The Company generates revenues from products which are sold into the human and animal healthcare markets.

 

The following table presents the Company’s disaggregated revenues by revenue source: 

           
    Three Months Ended June 30,  
Product   2022     2021  
Human Care   $ 2,168,000     $ 2,715,000  
Animal Care     787,000       812,000  
Service and Royalty     1,028,000       157,000  
Total   $ 3,983,000     $ 3,684,000  

 

 

The following table shows the Company’s revenues by geographic region: 

           
    Three Months Ended June 30,  
    2022     2021  
United States   $ 871,000     $ 1,592,000  
Latin America     1,048,000       565,000  
Europe and Rest of the World     2,064,000       1,527,000  
Total   $ 3,983,000     $ 3,684,000